Literature DB >> 18085993

Pharmacogenomics of microRNA: a miRSNP towards individualized therapy.

Joseph R Bertino, Debabrata Banerjee, Prasun J Mishra.   

Abstract

Mesh:

Substances:

Year:  2007        PMID: 18085993     DOI: 10.2217/14622416.8.12.1625

Source DB:  PubMed          Journal:  Pharmacogenomics        ISSN: 1462-2416            Impact factor:   2.533


× No keyword cloud information.
  19 in total

1.  MicroRNA polymorphisms: a giant leap towards personalized medicine.

Authors:  Prasun J Mishra
Journal:  Per Med       Date:  2009-03-01       Impact factor: 2.512

2.  Polymorphism in pre-miR-30c contributes to gastric cancer risk in a Chinese population.

Authors:  Yong-ping Mu; Xiu-lan Su
Journal:  Med Oncol       Date:  2011-11-23       Impact factor: 3.064

3.  Genome-wide analysis of microRNA and mRNA expression signatures in hydroxycamptothecin-resistant gastric cancer cells.

Authors:  Xue-mei Wu; Xiang-qiang Shao; Xian-xin Meng; Xiao-na Zhang; Li Zhu; Shi-xu Liu; Jian Lin; Hua-sheng Xiao
Journal:  Acta Pharmacol Sin       Date:  2011-02       Impact factor: 6.150

Review 4.  The emerging role of microRNAs in drug responses.

Authors:  Wei Zhang; M Eileen Dolan
Journal:  Curr Opin Mol Ther       Date:  2010-12

5.  Single nucleotide polymorphisms in microRNA binding sites of oncogenes: implications in cancer and pharmacogenomics.

Authors:  Mayakannan Manikandan; Arasambattu Kannan Munirajan
Journal:  OMICS       Date:  2013-11-28

Review 6.  MicroRNA polymorphisms: the future of pharmacogenomics, molecular epidemiology and individualized medicine.

Authors:  Prasun J Mishra; Joseph R Bertino
Journal:  Pharmacogenomics       Date:  2009-03       Impact factor: 2.533

7.  microRNAs: a role in drug resistance in parasitic nematodes?

Authors:  Eileen Devaney; Alan D Winter; Collette Britton
Journal:  Trends Parasitol       Date:  2010-06-11

Review 8.  A review of pharmacogenetics of adverse drug reactions in elderly people.

Authors:  Maurizio Cardelli; Francesca Marchegiani; Andrea Corsonello; Fabrizia Lattanzio; Mauro Provinciali
Journal:  Drug Saf       Date:  2012-01       Impact factor: 5.606

9.  The miRNA-drug resistance connection: a new era of personalized medicine using noncoding RNA begins.

Authors:  Prasun J Mishra
Journal:  Pharmacogenomics       Date:  2012-09       Impact factor: 2.533

10.  MiR-24 tumor suppressor activity is regulated independent of p53 and through a target site polymorphism.

Authors:  Prasun J Mishra; Bo Song; Pravin J Mishra; Yuan Wang; Rita Humeniuk; Debabrata Banerjee; Glenn Merlino; Jingfang Ju; Joseph R Bertino
Journal:  PLoS One       Date:  2009-12-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.